
The pharmaceutical industry is expected to grow rapidly due to global medical needs, technological advancements, an aging population, innovative treatments, precision medicine, and personalized healthcare.
Given the industry’s growth prospects, fundamentally strong pharma stocks Neurocrine Biosciences, Inc. (NBIX), AstraZeneca PLC (AZN) and Johnson & Johnson (JNJ) might be worth buying.